Scribe Therapeutics Inc. Common Stock (SCTX)

Scribe Therapeutics Inc. Common Stock (SCTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $380M; returns 1 day -14.2%, 1 week -23.3%.

Scribe Therapeutics is a clinical-stage biotechnology company specializing in the engineering of novel, purpose-built CRISPR molecules for in vivo genetic medicine.

Groups SCTX belongs to

• Biotechnology
• Recent IPOs
• Clinical Stage Biotech
• Clinical Stage
• Gene Therapy
• Precision Medicine
• Life Sciences
• Healthcare
• Healthcare Innovation
• R&D
• Strategic Partnerships

SCTX financial model: income statement, cash flow and balance sheet